| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |